Finished
CorPath® GRX Neuro Study
NCT04236856 · Siemens Healthineers Endovascular Robotics, Inc. · Updated 6 March 2025
- What is being tested
- Robotic Endovascular Procedure
- For
- Intracranial Aneurysm; Subarachnoid Hemorrhage; Headache
- Kind of study
- Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
- Who can join
- Ages 18 years and older. About 120 people. The full rules are on the registry page.
- Where
- Australia, Austria, Canada, France, Spain, Switzerland (10 sites)
- When
- Starts or started 21 Aug 2020, ends 12 Oct 2022. Registered 22 Jan 2020.
- Results
- Posted on the registry on 6 March 2025.
In the researchers' words
The primary objective of this study is to evaluate the effectiveness and safety of robotic-assisted endovascular embolization procedures compared to objective performance criteria for traditional, manual operation based on the scientific literature.
Sites
- Gold Coast University HospitalSouthport, Queensland, Australia
- Uniklinikum SalzburgSalzburg, Austria
- Toronto Western HospitalToronto, Ontario, Canada
- St. Michael's HospitalToronto, Canada
- Hôpital Pitié-SalpêtrièreParis, CA, France
- CHU Montpellier - Hôpital Gui de ChauliacMontpellier, France
- Hôpital de la Fondation RothschildParis, France
- Vall d'Hebron University HospitalBarcelona, Spain
- University Clinical Hospital of ValladolidValladolid, Spain
- Inselspital, Universitätsspital BernBern, Switzerland
